The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis

• Autores principales: Gianmarco Villano (Autor), Erica Novo (Autor), Cristian Turato (Autor), Santina Quarta (Autor), Mariagrazia Ruvoletto (Autor), Alessandra Biasiolo (Autor), Francesca Protopapa (Autor), Monica Chinellato (Autor), Andrea Martini (Autor), Elisabetta Trevellin (Autor), Marnie Granzotto (Autor), Stefania Cannito (Autor), Laura Cendron (Autor), Silvia De Siervi (Autor), Maria Guido (Autor), Maurizio Parola (Autor), Roberto Vettor (Autor), Patrizia Pontisso (Autor)
• Formato: Libro
• Publicado: Elsevier, 2024-03-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Objective: The serine protease inhibitor SerpinB3 has been described as critical mediator of liver fibrosis and it has been recently proposed as an additional hepatokine involved in NASH development and insulin resistance. Protease Activated Receptor 2 has been identified as a novel regulator of hep...